IMPORTANCE Cardiometabolic risk factors have been associated with an increased risk of dementia; yet, the optimal targets and time window for the management of cardiometabolic health to prevent dementia remain unknown.
A ppropriate control of cardiometabolic risk factors could be a primary strategy to reduce the incidence of dementia and its most common form, Alzheimer disease (AD). [1] [2] [3] [4] Epidemiologic studies found associations between overweight/obesity, hypertension, hypercholesterolemia, and diabetes in midlife and increased risk of dementia, 3, [5] [6] [7] [8] [9] [10] [11] [12] although some inconsistent findings were also reported. 13, 14 When measured in late life, cardiometabolic risk factors have been inconsistently associated with dementia, with both increased and decreased risks reported in epidemiologic research [15] [16] [17] [18] [19] [20] ; notable exceptions are high glucose levels and diabetes, which have been consistently associated with a greater cognitive decline and a higher risk of dementia.
14, [21] [22] [23] Limited research has examined trajectories of risk factors in the long period preceding dementia diagnosis. A few longitudinal studies have reported a decline in blood pressure (BP) and total cholesterol levels several years prior to dementia. 9, 18, 19 Likewise, a decline in both body mass index (BMI) and physical activity a few years before dementia diagnosis was reported in the Cardiovascular Risk Factors, Aging and Dementia 5 and Whitehall II 24,25 studies. To our knowledge, no large cohort study has concurrently examined the trajectories of all main cardiovascular risk factors in the years preceding dementia diagnosis, and the optimal targets and time windows in older ages for the management of cardiometabolic health for dementia prevention have remained unclear. The present study aimed to concurrently describe trajectories of major cardiometabolic risk factors up to 14 years preceding dementia diagnosis in a large, population-based cohort: the Three-City (3C) study. We used a case-control approach to contrast trajectories between individuals who developed dementia and dementia-free controls and identify time lags when their trajectories significantly differed. Based on previous studies on trajectories of cognition 26 and depressive symptoms 27 that showed acceleration of impairments in prodromal dementia, we established a priori that a stronger change of risk factors among dementia cases at the approach of diagnosis might reflect reverse causation. By contrast, different, yet parallel, evolutions between cases and controls may reflect causal association. For BP, the biological rationale was that both high values (mediated by cerebral vascular disease) and low values (mediated by hypoperfusion) may cause brain injury 28 ; thus, we set that a lower trajectory among cases may indicate either reverse causation or causal association.
Methods

Population
The 3C study is an ongoing, prospective cohort that started in 1999 including 9294 noninstitutionalized participants aged 65 years or older from 3 French cities (Bordeaux, 2104; Dijon, 4931; and Montpellier, 2259). 29 At baseline (hereafter labeled T 0 ) and at follow-up visits attended every 2 to 3 years until 2014, trained psychologists conducted an in-person interview including assessment of sociodemographic, lifestyle, and medical information (including recording of current medication use 30 ), neuropsychological testing, and anthropometric and BP measurements. In Bordeaux and Montpellier, 6 follow-up visits were carried out 2, 4, 7, 10, 12, and 14 years after inclusion (hereafter labeled T 2 ,T 4 ,T 7 ,T 10 ,T 12 , and T 14 respectively). In Dijon, 5 follow-up visits were conducted at T 2 ,T 4 ,T 7 ,T 10 , and T 12 . Moreover, a blood sample was collected on 3 occasions in Bordeaux (T 0 ,T 4 ,T 10 ) and 2 occasions in Montpellier (T 0 ,T 10 ) and Dijon (T 0 ,T 4 ). All participants provided written consent, and the study protocol was approved by the ethics committee of the Kremlin-Bicêtre University-Hospital, Paris, France. Participants do not receive financial compensation.
Diagnosis of Dementia
At each visit, diagnosis of dementia was based on a 2-step procedure. 29 Neurologists examined participants with suspected dementia based on their neuropsychological performances. Diagnosis and cause of dementia were then reviewed and validated by an independent expert committee of neurologists and geriatricians with expertise in dementia following the criteria of the DSM-IV. Alzheimer disease cases were classified as possible or probable using the National Institute of Neurological and Communicative Disorders and StrokeAlzheimer Disease and Related Disorders Association criteria.
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Nested Case-Control Sample
Among the initial 9294 potential participants evaluated at baseline, we excluded 651 individuals for whom no blood sample was available (n = 576) or who were not fasting (n = 75), 173 prevalent cases of dementia, and 551 persons with at least 1 missing value among the cardiometabolic measures of interest. Moreover, we excluded 576 individuals without at least 1 follow-up visit after inclusion and 3 with a missing educational level. To avoid a large incertitude on the date of dementia onset, we also excluded 36 incident cases for whom no negative diagnosis was established in the last 2 visits preceding the positive diagnosis. Among the 7304 remaining individuals, 841 developed dementia during the follow-up period. Each dementia case was matched to 4 controls at the diagnosis visit. To ensure independence of control samples across every risk set, 32 we used random sampling with replacement between visits (and without replacement within a same
Key Points
Question What are the trajectories of the established cardiometabolic risk factors in the 14 years before incidence of dementia?
Findings In this nested case-control study of 3925 participants, both body mass index and blood pressure trajectories of future dementia cases deviated from those of dementia-free controls, leading to lower levels at the approach of diagnosis, whereas trajectories of blood lipid levels remained roughly similar between incident dementia cases and matched controls. Elevated glycemia was the only cardiometabolic risk factor with constantly higher values among dementia cases up to 14 years before diagnosis.
Meaning Appropriate control of elevated glycemia levels and screening of both low blood pressure and weight loss may be key components of cardiovascular health management for the primary and secondary prevention of dementia in older persons.
follow-up visit). To be included in the control sample, individuals had to be (1) both examined and free of dementia at the matching visit, (2) from the same cohort center as the case, and (3) of similar sex, age (±3 years), and educational level (coded in 3 classes: less than high school, high school, and more than high school). Among the 841 incident cases identified in the initial study sample, 785 (93.3%) were successfully matched to 4 controls, leading to a nested case-control study sample of 3925 individuals.
Ascertainment of Cardiometabolic Risk Factors
We investigated the trajectories of cardiometabolic variables through repeated measures of BMI, systolic BP (SBP), diastolic BP (DPB), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides, and blood glucose levels. The BMI was computed as weight in kilograms divided by height in meters squared, using height measured (or self-reported for 25.4% of cases and 26.3% of controls) at baseline and weight measured (or selfreported for 43.7% of cases and 44.2% of controls) at T 0 and T 2 and self-reported thereafter. Blood pressure was measured twice on the right arm with the participant in a sitting position. 29 We used the mean of the 2 measures or the single measure for 2.0% over all repeated measures when 1 measure was missing. Fasting total cholesterol, HDL-C, triglycerides, and blood glucose levels were measured using standard enzymatic methods. The LDL-C level was computed according to the Friedwald equation.
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Statistical Analysis
Mean trajectories of each cardiometabolic risk factor were estimated using latent-process mixed models (ie, mixed models that handle non-Gaussian longitudinal markers as reported in the eMethods in the Supplement). 34 We used retrospective time since the matching visit as the timescale (in years); thus, for each quintet (1 case, 4 matched controls), year 0 was the diagnosis visit of the case. Models included a quadratic function of retrospective time and were adjusted for case-control status, matching variables (age, sex, educational level, and cohort center), and their interactions with both time and time squared. The withinparticipant correlation was captured by correlated random intercept and slopes on time and time squared. For BP, models included 2 additional indicators to control for potential whitecoat effect (eMethods and eFigure 1 in the Supplement).
We tested the differences in trajectories between cases and controls using Wald tests. Two comparisons were made. First, we compared risk factor trajectories during the entire time through a global evaluation of group-by-time interactions. Second, we compared mean predicted risk factor values at different time points. For the latter measures, we primarily used the nominal 5% significance level and secondarily used a corrected threshold to account for the multiple testing (eMethods in the Supplement). Significance was determined using 2-tailed, unpaired testing. The primary significance level considered overall was 5%; the thresholds then corrected for test multiplicity were 1.9% for BMI, 1.3% for BP, and 1.2% for blood lipid and glucose levels.
We used SAS, version 9.4 (SAS Institute Inc) and macro %match 35 for the selection of controls, and R, version 3.3.1 (R Foundation) and lcmm function of lcmm package, version 1.7.8 36 for latent process mixed models. eAppendix in the Supplement provides the R code to reproduce the analyses. Data analysis was performed in September 2017.
Supplementary Analyses
Several additional analyses were performed. We investigated trajectories of each cardiometabolic risk factor among 2 dementia subtypes: possible or probable AD and mixed dementia or vascular dementia (VD). For biological factors, we also explored whether differences in trajectories between cases and controls were modified by the total number of medications at baseline and by factor-specific medication use during follow-up (eMethods and eTable 1 in the Supplement). Finally, we conducted sensitivity analyses to evaluate (1) the association between diabetes status and glycemia trajectories (excluding participants with diabetes during the study period) and (2) the robustness of our findings to statistical assumptions (eMethods in the Supplement).
Results
The 
Trajectories of Cardiometabolic Risk Factors Preceding Dementia
For each cardiometabolic risk factor, trajectories were represented retrospectively from the matching visit among cases and controls for the most common profile of covariates ( Figure 1, Figure 2 , Figure 3 , and Figure 4 ; see eFigure 2 in the Supplement for trajectories from a nonadjusted model and eFigure 3 in the Supplement for observed mean cardiometabolic values). Mean BMI declined significantly over time for both cases and controls (Figure 1 , with no significant difference in the overall change between the 2 groups (P = .29 for group-by-time interaction). However, compared with controls, predicted glucose levels were constantly higher among cases during the study period, with significant differences in a large window spanning from 1.6 years to 14.0 years before the matching visit. The global observations were normalized by I-splines with 2 internal knots. Trajectories were plotted for the most common profile of the study sample: a woman from an average study center, aged 76 years at inclusion and with educational level lower than high school. Note that the choice of the profile affects only the level of the trajectories; it does not affect the differences between cases and controls or test significance. . Blood pressure observations were normalized by I-splines with 2 internal knots. Trajectories were plotted for the most common profile of the study sample: a woman from an average study center, aged 76 years at inclusion, and with educational level lower than high school. Note that the choice of the profile affects only the level of the trajectories; it does not affect the differences between cases and controls or test significance. 
Supplementary Analyses
In the sub-case-control samples of AD and VD, cardiometabolic trajectories were generally similar to those found in the all-cause dementia sample (eFigure 4 in the Supplement), although most differences did not reach statistical significance (except for blood glucose levels). When considering medication use, neither polymedication at baseline nor factor-specific medication during follow-up were differently associated with trajectories of biological factors (all P values for global interaction tests ≥.07), suggesting that medication had little association with the differential trajectories between cases and controls. When excluding participants with diabetes, the shapes of the trajectory in both groups were roughly the same as those found in the main analysis (eFigure 5 in the Supplement), suggesting that glucose levels were higher among dementia cases than controls, even in the nondiabetic population. Results also remained virtually unchanged when we log-transformed triglyceride . Plasma lipid level observations were normalized by I-splines with 3 internal knots. Trajectories were plotted for the most common profile of the study sample: a woman from an average study center, aged 76 years at inclusion, and with educational level lower than high school. Note that the choice of the profile affects only the level of the trajectories; it does not affect the differences between cases and controls or test significance. To convert HDL and LDL cholesterol to millimoles per liter, multiply by 0.0259; triglycerides to millimoles per liter, 0.0113.
Research Original Investigation
Concurrent Trajectories of Cardiometabolic Risk Factors in the 14 Years Before Dementia and glucose levels (eFigure 6 in the Supplement)o r re-estimated the models by allowing more flexible trajectories over time with natural cubic splines (eFigure 7 in the Supplement).
Discussion
In this large prospective cohort spanning 14.0 years in olderaged participants, we found (1) a general decline of BMI, DBP, and HDL-C levels with aging, (2) an increase of SBP and blood glucose levels, and (3) a stable evolution of non-HDL-C lipid levels. Moreover, evolution of several risk factors diverged in prodromal dementia. Compared with controls, dementia cases had a steeper decline of BMI up to 7 years before diagnosis. Cases also had a significantly slower SBP increase, consistently lower DBP values, and higher glucose levels. Finally, blood lipid trajectories did not significantly differ. Thus, overall in prodromal dementia compared with natural aging, BMI and BP decreased and glucose was the only risk factor with constantly higher levels. These trajectories were based on observational findings, and any conclusion regarding causal associations should be made with caution. However, there is a biological rationale supporting the interpretation of BMI and BP trajectories in prodromal dementia toward reverse causation because of incipient evolution of neuropathologic changes and subtle cognitive impairment (trajectories of cognition and depressive symptoms show progressive prediagnosis acceleration in eFigure 8 in the Supplement). Yet, because low BP may cause hypoperfusion and lead to brain damage, the lower BP in prodromal dementia may also reflect a causal association. Finally, these findings suggest that elevated glucose levels may be a risk factor for dementia in the older age range.
The decline of BMI and HDL-C found with general aging in this cohort and in previous studies 37-43 may reflect weight loss and malnutrition associated with the loss of muscle mass, appetite, and olfactory function in older persons. Likewise, the increase of SBP and decrease of DBP may be a consequence of age-related development of large-artery stiffness and atherosclerosis. 44 Aging also affects glucose homeostasis, 45 leading to glucose intolerance, insulin resistance, and consequent elevation of blood glucose levels as observed in our study and others.
39,43
Beyond general age-related biological changes, our longitudinal approach revealed specific risk factor evolutions in prodromal dementia. A decrease in both BMI and BP in the years preceding dementia has been found in previous cohorts, In our cohort, blood glucose level was the only cardiometabolic factor with consistently higher mean levels among dementia cases compared with controls up to 14.0 years prior to diagnosis, even among participants who remained free of diabetes during the study. An increased risk of dementia associated with higher blood glucose levels, even in the normoglycemic range, over the preceding 5 years was previously demonstrated. 21 Elevated glucose levels could damage the brain through multiple mechanisms, including insulin resistance, cerebral small vessel disease, and brain accumulation of amyloid.
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Strengths and Limitations
This study has several strengths. Trajectories were based on a large, community-based prospective study over a long follow-up, with longitudinal assessment of cardiometabolic health based mostly on objective measures, standardized clinical assessment of dementia, and a consensus-based clinical diagnosis. We applied a rigorous methodologic approach using incidence density case-control sampling that ensured formal statistical testing of differences between groups, coupled with a flexible statistical model capable of capturing nonlinear trajectories and handling non-Gaussian markers. Finally, by concurrently exploring trajectories of main cardiometabolic factors, our study helps to disentangle the risk factors for dementia (ie, elevated glucose levels, low BP) from risk factors potentially reflecting early preclinical disease (eg, decreased BMI). Our study also has limitations. The 3C study includes French participants-mostly urban-and our findings may not apply to populations from different sociogeographic origins. Furthermore, although based on a long follow-up period, we did not cover early windows of exposures (eg, since midlife); thus, our results may not generalize to prevention in early adulthood. Moreover, cardiometabolic health factors were ascertained through a limited and somehow imperfect list of longitudinal risk factors. For instance, the waist to hip ratio may be a more sensitive indicator of cardiovascular disease risk than BMI. 63 However, both BMI and waist to hip ratio demonstrated similar associations with risk of cardiovascular diseases in a previous study, suggesting that BMI appropriately captures risk for adverse health. 64 Finally, the number of repeated measures for biological variables was small. Although using retrospective time since diagnosis as a timescale enabled biological data to be continuously observed over the study period, differences remote from diagnosis should be interpreted with caution because they are based on limited data.
Conclusions
Management of cardiometabolic health may be a key component of dementia prevention. Yet, with metabolic changes owing to both aging and potential underlying chronic diseases, including dementia, studies in older persons have been discordant, and there is no clear consensus on the strategy to use for their management in late adulthood for the purpose of delaying or preventing dementia onset. Most previous studies have examined risk factors individually and did not formally model trajectories over a long time prior to dementia. By modeling concurrently the trajectories of main cardiometabolic risk factors in prodromal dementia in a large prospective cohort, we provide evidence that BMI declines several years before dementia diagnosis and might indicate preclinical disease, whereas BP, specifically DBP, is consistently lower among future dementia cases, which may reflect both underlying disease and a causal association between low BP and dementia. Finally, elevated glucose levels over the course of older adulthood were higher among those who eventually developed dementia and may thus represent a risk factor for dementia. Whether confirmed and extended to other populations, these findings emphasizing blood glucose control, low BP, and weight loss as key components of cardiovascular health management for primary and secondary prevention of dementia in older persons may have important implications for preventive care practice in geriatric populations. This supplementary material has been provided by the authors to give readers additional information about their work.
eMethods. Detailed Methodology Statistical model
Latent process mixed models were used to model the mean trajectory of each cardiometabolic factor according to time (assuming a quadratic trajectory with time and time squared), case-control grouping and confounding factors. The latent process mixed model is a mixed model that handles possibly non-Gaussian longitudinal markers; the marker is transformed to correct the departure from the normal distribution using parameterized link functions. 1 For each cardiometabolic risk factor, the optimal link function was selected according to the Akaike Information Criterion among link functions based on quadratic I-splines with three to five knots and the linear link function. For SBP and DBP specifically, models included two additional binary indicators (measure taken at T 0 versus later; measure based on the average of two measures versus one measure) to control for potential "white coat effect" (i.e., the transient increase in blood pressure induced by the stress associated with a primary clinical examination). Such white coat effect on blood pressure measures in our cohort is illustrated in eFigure 1. As generally recommended when there is no intuitive reference group for a covariate, the 3-category study center variable was coded using a contrast in which the reference was set to the average of covariate modalities. Thus, the reference group belonged to an "average" study center in the analyses.
Wald tests of the differences in trajectories between cases and controls
We tested the differences in trajectories between cases and controls using Wald tests. Two types of comparisons were made. First, we compared risk factor trajectories over the entire time period, through a global evaluation of group-by-time interactions (i.e., simultaneous evaluation of interactions parameters between case-control status and both time and time squared). Second, we compared mean predicted risk factor values at different time points. For the latter, we primarily used the nominal 5% significance level. In secondary analyses, we also used a corrected threshold (based on the joint distribution of the statistics over pre-specified time points [two-year backward intervals from dementia diagnosis]) to account for the multiple testing. 
Supplementary analyses: robustness to model hypotheses
For triglycerides and glycemia, which had extreme asymmetric distributions, we investigated the ability of the quadratic I-splines link functions to correctly normalize the data by comparing our results with trajectories obtained when log-transforming the data before applying the normalization. We also compared the quadratic trajectories with more flexible functions of time (regression splines with two internal knots). Mean trajectories with 95% pointwise confidence intervals were predicted by a latent process linear mixed model in the retrospective time since the matching visit. The models included: a quadratic function of time (t, t 2 ); case-control status and its interaction with the quadratic function of time; correlated random effects on the intercept, time and time squared (models for SBP and DBP also included two binary indicators for white coat effect [value measured at T0 yes/no, and value based on average of two measures versus one measure]). Observations were normalized by I-spline. Trajectories were plotted for the general profile of the study sample. P(t²,t)xCase corresponds to the p-value of the Wald test evaluating the overall difference in change over time across groups (simultaneous evaluation of time and time squared parameters). Mean trajectories with 95% pointwise confidence intervals were predicted by a latent process linear mixed model in the retrospective time since the matching visit. The models included: a quadratic function of time (t, t 2 ); case-control status, matching variables (i.e., gender, age, education, and cohort center), and their interactions with the quadratic function of time; and correlated random effects on the intercept, time and time squared. Glucose observations were normalized by I-splines with 3 internal knots. Trajectories were plotted for the most common profile of the study sample: a woman from an average study center, aged 76 years at inclusion and with educational level<high school. Note that the choice of the profile only impacts the level of the trajectories and it does not affect the differences between cases and controls. Number of observations for cases and controls is given at the bottom per 2-year interval. P(t²,t)xCase corresponds to the p-value of the Wald test evaluating the overall difference in change over time across groups (i.e., simultaneous evaluation of time and time squared parameters). Mean trajectories with 95% pointwise confidence intervals were predicted by a latent process linear mixed model in the retrospective time since the matching visit. Trajectories were approximated by natural splines (two internal knots) and the models included case-control status, matching variables (i.e., gender, age, education, and cohort center), and their interactions with the function of time as well as correlated random effects on the intercept and function of time. Observations were normalized by I-splines. Trajectories were plotted for the most common profile of the study sample: a woman from an average study center, aged 76 years at inclusion and with educational level<high school. Note that the choice of the profile only impacts the level of the trajectories; it does not affect the differences between cases and controls or the tests significance (not showed here).
